ROIVANT SCIENCES LTD. Long-Term Debt
ROIVANT SCIENCES LTD. (ROIV) had Long-Term Debt of $210.03 million as of 2022-03-31, per its 10-K filed 2022-06-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermDebtNoncurrent · last filed 2022-06-28
- 2022-03-31: Long-term Debt, Excluding Current Maturities $210.03M.
- 2021-12-31: Long-term Debt, Excluding Current Maturities $204.04M.
- 2021-09-30: Long-term Debt, Excluding Current Maturities $199.87M.
- 2021-06-30: Long-term Debt, Excluding Current Maturities $186.35M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2022-03-31 | $210.03M 10-K · filed 2022-06-28 |
| 2021-12-31 | $204.04M 10-Q · filed 2022-02-14 |
| 2021-09-30 | $199.87M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $186.35M 10-Q · filed 2021-09-21 |
| 2021-03-31 | $170.28M 10-K · filed 2022-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |